Larimar Therapeutics, Inc.

NASDAQ (USD): Larimar Therapeutics, Inc. (LRMR)

Last Price

4.32

Today's Change

-0.51 (10.55%)

Day's Change

4.13 - 4.77

Trading Volume

2,371,626

Overview

Market Cap

275 Million

Shares Outstanding

63 Million

Avg Volume

839,850

Avg Price (50 Days)

7.14

Avg Price (200 Days)

7.75

PE Ratio

-3.76

EPS

-1.15

Earnings Announcement

12-Mar-2025

Previous Close

4.83

Open

4.71

Day's Range

4.1349 - 4.77

Year Range

3.01 - 13.68

Trading Volume

2,372,662

Price Change Highlight

1 Day Change

-10.56%

5 Day Change

-30.32%

1 Month Change

-29.87%

3 Month Change

-36.93%

6 Month Change

-45.11%

Ytd Change

-15.46%

1 Year Change

4.60%

3 Year Change

-58.66%

5 Year Change

-50.00%

10 Year Change

-98.51%

Max Change

-98.18%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment